Lenalidomide
Active Purchase Order Awarded Last action
- Contract number
- 36C25226P0149
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,763,079
Award facts
- Opportunity
-
- Lenalidomide Solicitation · 36C25226Q0160 · Posted Dec 22, 2025
- Contract value 100% obligated
- $1,763,078.79 Current and potential, with all options
- Completion date 80% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $418,243 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,344,836 |
About this award
Veterans Integrated Service Network 12 awarded a purchase order to Exelan Pharmaceuticals Inc. for Lenalidomide supply on January 16, 2026, with a ceiling value of $1,763,078.79. The order represents a quantity change and additional funds modification to an existing purchase order.
Performance occurs at Boca Raton, Florida, with medication delivery to Tomah VA Medical Center in Wisconsin. The requirement covers Lenalidomide/Revlimid in multiple dosages (2.5 mg, 5 mg, 10 mg, 15 mg, and 25 mg) for treatment of multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, and follicular lymphoma. The vendor must maintain Lenalidomide REMS program certification and provide next-day delivery with signature confirmation; shipping fees are capped at $250 per order. The order is firm fixed price with no set-aside. Performance extends through January 15, 2027. The underlying solicitation was posted December 22, 2025, with award evaluation on a lowest-price technically acceptable basis.
Quick answers
Who was awarded contract 36C25226P0149?
36C25226P0149 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on January 16, 2026.
How much is contract 36C25226P0149 worth?
The government has obligated $1,763,079 on 36C25226P0149.
Was contract 36C25226P0149 competed?
The extent of competition for 36C25226P0149 was full and open competition. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award